Estevez Hector, Palacios Ainhoa, Gil David, Anguita Juan, Vallet-Regi Maria, González Blanca, Prados-Rosales Rafael, Luque-Garcia Jose L
Department of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, Madrid, Spain.
Inflammation and Macrophage Plasticity Lab, CIC bioGUNE, Derio, Spain.
Front Microbiol. 2020 Apr 28;11:800. doi: 10.3389/fmicb.2020.00800. eCollection 2020.
Tuberculosis (TB) remains the leading cause of death from a single infection agent worldwide. In recent years, the occurrence of TB cases caused by drug-resistant strains has spread, and is expected to continue to grow. Therefore, the development of new alternative treatments to the use of antibiotics is highly important. In that sense, nanotechnology can play a very relevant role, due to the unique characteristics of nanoparticles. In fact, different types of nanoparticles have already been evaluated both as potential bactericides and as efficient drug delivery vehicles. In this work, the use of selenium nanoparticles (SeNPs) has been evaluated to inhibit the growth of two types of mycobacteria: () and (). The results showed that SeNPs are able to inhibit the growth of both types of mycobacteria by damaging their cell envelope integrity. These results open a new opportunity for the use of this type of nanoparticles as antimycobacterial agents by themselves, or for the development of novel nanosystems that combine the action of these nanoparticles with other drugs.
结核病(TB)仍然是全球单一感染源导致死亡的首要原因。近年来,由耐药菌株引起的结核病病例不断蔓延,且预计还会持续增加。因此,开发抗生素之外的新型替代疗法至关重要。从这个意义上讲,由于纳米颗粒具有独特特性,纳米技术可发挥非常重要的作用。事实上,不同类型的纳米颗粒已被评估为潜在的杀菌剂和高效的药物递送载体。在这项工作中,已对硒纳米颗粒(SeNPs)抑制两种分枝杆菌生长的能力进行了评估:()和()。结果表明,SeNPs能够通过破坏两种分枝杆菌的细胞膜完整性来抑制其生长。这些结果为将此类纳米颗粒单独用作抗分枝杆菌剂,或开发将这些纳米颗粒与其他药物的作用相结合的新型纳米系统开辟了新机遇。